Skip to main content
. 2016 Dec 21;8(17):29370–29382. doi: 10.18632/oncotarget.14083

Figure 5. Alterations of cTh22 cells and cTh17 cells in the acute and convalescent patients with EV71-associated HFMD.

Figure 5

A.-B. The percentage changes in cTh22 cells in PBMCs from mild A. and severe B. patients. C.-D. The percentage changes in cTh17 cells in PBMCs from mild C. and severe D. patients